Patent For Therapeutic Skin Treatment Awarded to Topix Pharmaceuticals

US Patent No. 11,433,006 B2 (Steven M. Hernandez); Topix Pharmaceuticals, Inc., North Amityville, NY, has been awarded a patent for a topical therapeutic treatment for skin in dermatological procedures. It is comprised of sodium hyaluronate; an oligopeptide (wherein the oligopeptide is 0.0001%-10% palmitoyl sh-tripeptide-4 amide on an active basis); one or more antioxidants (wherein the one or more antioxidants is between 0.1%-10% w/w and comprises one or more of Camellia sinensis leaf extract, resveratrol, ectoin, Cucumis satvius fruit extract, ergothioneine, Phyllanthus emblica fruit extract); purified water; hydrolyzed sodium hyaluronate; Camellia sinensis leaf extract; resveratrol; ectoin; ergothioneine; bisabolol; Cucumis satvius fruit extract; sodium pyrrolidone carboxylic acid (PCA); Chamomila recutita flower extract; comfrey extract; yucca glauca root extract; Phyllanthus emblica fruit extract; caffeine; sodium phosphate; potassium hydroxide; phenylcarbinol; sodium benzoate; disodium Ethylenediaminetetraacetic acid (EDTA); and polysorbate 20.